Bioharvest Sciences Inc. (BHST)
Strength Seen in BioHarvest Sciences Inc. (BHST): Can Its 12.7% Jump Turn into More Strength?
BioHarvest Sciences Inc. (BHST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BioHarvest Sciences appoints veteran technology leader to board of directors
BioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) has announced the appointment of seasoned technology executive Sharon Malka as an independent director of the company. Malka brings extensive leadership experience to BioHarvest, with a background spanning international healthcare and technology companies.
BioHarvest Sciences positioned for ‘legacy year' in 2025, building on momentum with new innovations and strategic collaborations
BioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) is poised to capitalize on key trends shaping the health and wellness industry in 2025, including a growing focus on sustainability, longevity-driven health solutions, and plant-based innovation. “The notions of sustainability, longevity, and the recognition of the power that exists in plants from consumers and industry are three critical trends that are really driving tailwinds,” Ilan Sobel, BioHarvest Sciences CEO, told Proactive.
BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growth
BioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) CEO Ilan Sobel has reflected on 2024 as “a year of transformation and growth” for the company. In a letter to shareholders, Sobel highlighted the launch of the company's Contract Development and Manufacturing Organization (CDMO) Services division as “the most transformational change in 2024” for BioHarvest.
BioHarvest Sciences CEO discusses Tate & Lyle partnership - ICYMI
BioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) this week announced a significant move for the company, a partnership with Tate & Lyle to develop plant-based sweeteners. The collaboration aims to create botanical, plant-derived sweeteners that are sustainable, low-calorie, and offer superior taste.
BioHarvest Sciences Inc. (BHST) Q3 2024 Earnings Call Transcript
BioHarvest Sciences Inc. (NASDAQ:BHST ) Q3 2024 Earnings Conference Call November 25, 2024 4:30 PM ET Company Participants Justin Meiklem - IR Ilan Sobel - CEO Bar Dichter - CFO Zaki Rakib - President of Botanical Synthesis CDMO Business Unit Conference Call Participants Hunter Diamond - Diamond Equity Research Operator Greetings, and welcome to the BioHarvest Sciences Third Quarter 2024 Corporate Update Conference Call. At this time, all participants are in a listen-only mode.
BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Misses Revenue Estimates
BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to break-even earnings per share a year ago.
BioHarvest Sciences reports increased revenues, profits for Q3
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) reported robust financial performance for the third quarter ending September 30, 2024. The company achieved a 101% year-over-year revenue increase to $6.5 million, surpassing management's guidance.
BioHarvest Sciences launches VINIA SuperFood Teas
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) has expanded its product offerings with the launch of VINIA SuperFood Functional Teas, marking a strategic move into the $3.3 billion North American functional tea market. The new line features four premium blends: Black Tea, Green Tea, Matcha Green Tea, and Cranberry Hibiscus Herbal Tea, each infused with piceid resveratrol, the active ingredient from the company's clinically validated VINIA supplements.
